Getein has showcased its latest inventions at AACC Annual Meeting & Clinical Lab Expo 2018, the world's largest exposition for clinical laboratory products and services. The annual expo, kicked off at McCormick Place in Chicago on 31 July, 2018, attracted more than 830 exhibitors and about 21300 industry professionals from around the world.
One of our invention that drew much attention at the event was Getein 1600 Automated Immunofluorescence Quantitative Analyzer (briefed as Getein 1600), a state-of-the-art product within Getein’s point-of-care portfolio. Getein 1600 is fully automatic, high throughput with reliable performance for up to 48 samples and three individual cassettes for multiplex test items. Its ability to measure cTnI, NT-proBNP, CK-MB/cTnI/Myo, PCT, hs-CRP+CRP, D-Dimer, mAlb, NGAL, CysC, β2-MG and HbA1c enables the anal yzer a suitable diagnostic instrument for central laboratory.
Other highlights were Getein1100 Immunofluorescence Quantitative Analyzer, FIA8000 Quantitative Immunoassay Analyzer, FIA8600 Quantitative Immunoassay Analyzer, and POCT kits for cardiovascular, inflammatory, fertility, renal function, diabetes, hormone and many others, which support clinicians to make accurate diagnoses, prescribe treatments, as well as effective prognosis.
What’s more, MAGICL 6800 Chemiluminescence Immunoassay Analyzer, CM-800 Chemistry Analyzer and Getein 3200 Integrated System are coming to the overseas market soon, which have aroused many professionals’ attention in AACC due to their excellent performance。
As one of the main players in point-of-care industry worldwide, Getein’s mission- Pursue Excellence and Deliver Health - means a commitment to keep patients’ wellbeing in mind, We strive to deliver high-quality, reliable, and affordable rapid point-of-care and diagnostic solutions to professional clinical laboratories, hospitals, and physician offices.”